A Neuropathology Case Report of a Woman with Down Syndrome who Remained Cognitively Stable
Liou, J.-J.; Lou, J.; Nakagiri, J.; Yong, W.; Hom, C. L.; Doran, E. W.; Totoiu, M.; Lott, I.; Mapstone, M.; Keator, D. B.; Brickman, A. M.; Wright, S.; Nelson, B.; Lai, F.; Xicota, L.; Dang, L.-H. T.; Li, J.; Santini, T.; Mettenburg, J. M.; Ikonomovic, M. D.; Kofler, J.; Ibrahim, T.; Head, E.
Show abstract
In this neuropathology case report, we present findings from an individual with Down syndrome (DS) who remained cognitively stable despite Alzheimers disease (AD) neuropathology. Clinical assessments, fluid biomarkers, neuroimaging, and neuropathological examinations were conducted to characterize her condition. Notably, her ApoE genotype was E2/3, which is associated with a decreased risk of dementia. Neuroimaging revealed stable yet elevated amyloid profiles and moderately elevated tau levels, while neuropathology indicated intermediate AD neuropathologic change with Lewy body pathology and cerebrovascular pathology. Despite the presence of AD pathology, the participant demonstrated intact cognitive functioning, potentially attributed to factors such as genetic variations, cognitive resilience, and environmental enrichment. The findings suggest a dissociation between clinical symptoms and neuropathological changes, emphasizing the complexity of AD progression in DS. Further investigation into factors influencing cognitive resilience in individuals with DS, including comorbidities and social functioning, is warranted. Understanding the mechanisms underlying cognitive stability in DS could offer insights into resilience to AD neuropathology in people with DS and in the general population and inform future interventions.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.